As of Feb 27
| +0.63 / +2.59%|
The 7 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 25.00, with a high estimate of 34.00 and a low estimate of 24.00. The median estimate represents a 0.00% increase from the last price of 25.00.
The current consensus among 7 polled investment analysts is to Buy stock in PharMerica Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.